Core Viewpoint - The China Securities Regulatory Commission (CSRC) has demonstrated a strong commitment to regulatory enforcement in January 2026, with significant penalties imposed on various market participants, reflecting a "zero tolerance" approach towards violations in the capital market [1][10]. Group 1: Regulatory Actions and Penalties - In January 2026, the CSRC has imposed administrative penalties on at least 13 institutions and 25 individuals, with total fines exceeding 1.1 billion yuan [1]. - A notable case involved Yu Han, who was fined a total of 1.022 billion yuan for market manipulation, effectively nullifying his illicit gains and imposing additional penalties [2]. - The regulatory actions have extended to private equity firms, listed companies, and intermediaries, with significant fines imposed on Zhejiang Ruifengda Asset Management Co., Ltd. and others for serious violations of private fund regulations, totaling 41.3191 million yuan [3]. Group 2: Comprehensive Coverage of Violations - The CSRC has targeted not only traditional market manipulation but also financial fraud, with penalties for companies like Luqiao Information and *ST Changyao for financial misrepresentation, amounting to 21.5 million yuan and 10 million yuan respectively [3]. - The penalties also include fines for companies that have been delisted, such as Jiangsu Sunshine and Puli Pharmaceutical, which were fined 3.3 million yuan and 700,000 yuan respectively for disclosure violations [4]. - The regulatory framework emphasizes accountability across all levels, including individuals, companies, and intermediaries, indicating a shift towards more comprehensive and penetrating oversight [4][5]. Group 3: Enhanced Enforcement Mechanisms - The CSRC has improved the connection between administrative penalties and criminal prosecution, enhancing the overall effectiveness of punishment for securities violations [6]. - Recent cases, such as the criminal detention of Zhang Jun, the actual controller of Left River Technology, highlight the proactive approach of the CSRC in addressing serious violations [6]. - The regulatory environment is evolving towards a more integrated accountability system, aiming to deter financial misconduct and protect investor rights [6][10]. Group 4: Accelerated Enforcement Pace - The CSRC has shown a faster response in investigating and penalizing misleading statements and significant omissions by listed companies, with cases like Rongbai Technology being investigated within days of the alleged violations [7][8]. - The swift actions taken by the CSRC are intended to minimize the impact of illegal activities on the market and reinforce the importance of compliance [7][10]. - The regulatory body has indicated that the stringent enforcement measures will continue throughout 2026, maintaining a strong stance against financial misconduct [10].

Core Viewpoint - The company *ST Changyao is facing imminent delisting due to multiple risks, including trading, financial, and major legal violations, despite a temporary stock price surge of over 100% in four days [1][3]. Group 1: Delisting Risks - As of January 21, 2026, *ST Changyao's stock price was 0.64 CNY per share, having been below 1 CNY for fifteen consecutive trading days, with a market capitalization under 300 million CNY for nine days [2][9]. - The company is projected to have negative equity by the end of 2025, further complicating its financial situation [2][9]. - On January 23, 2026, the China Securities Regulatory Commission (CSRC) issued an administrative penalty decision, confirming the company's financial fraud over three years, which triggered the delisting process [3][10]. Group 2: Financial Fraud - The company has been found to have inflated its revenue by 215 million CNY, 284 million CNY, and 234 million CNY in the years 2021, 2022, and 2023 respectively, totaling over 700 million CNY in inflated revenue [5][11]. - The fraud involved not only surface-level data manipulation but also specific project confirmations, leading to an inflated profit of 4.55 million CNY due to improper loss recognition on a project [12]. - The CSRC has imposed a fine of 10 million CNY on the company and a total of 31 million CNY on 14 responsible individuals, with the former general manager banned from the securities market for life [5][12]. Group 3: Investor Rights and Compensation - The company’s restructuring plan has largely failed, with a court ruling against a restructuring application on December 29, 2025 [6][13]. - Investors affected by the company's situation have avenues for compensation, with specific timeframes for eligibility to file claims [7][14]. - The company’s stock was officially suspended from trading on January 26, 2026, as the delisting process commenced [6][10].

Group 1 - The average stock price of A-shares is 14.77 yuan, with 30 stocks priced below 2 yuan, the lowest being *ST Aowei at 0.69 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 26.67% of the total [1] - The Shanghai Composite Index closed at 4132.61 points on January 26 [1] Group 2 - The top gainers among low-priced stocks include ST Jinglan, Chongqing Steel, and ST Mingcheng, with increases of 5.20%, 1.95%, and 1.17% respectively [1] - The largest declines were seen in *ST Lifang, *ST Aowei, and Yabo shares, with decreases of 12.21%, 5.48%, and 3.23% respectively [1] - The stock with the highest trading volume among low-priced stocks is *ST Lifang, with a turnover rate of 16.76% [1]

Core Viewpoint - Changjiang Pharmaceutical Holdings Co., Ltd. (*ST Changyao) has been penalized by the China Securities Regulatory Commission (CSRC) for financial misconduct, including false reporting of revenue and profits from 2021 to 2023, which may lead to significant legal and financial repercussions for the company and its investors [2][3][9]. Group 1: Financial Misconduct Details - In November 2020, *ST Changyao acquired 52.75% of Hubei Changjiang Star Pharmaceutical Co., Ltd. and subsequently included it in its financial statements [2][7]. - From 2021 to 2023, the subsidiaries of Changjiang Star fabricated inventory and sales documents, resulting in inflated revenues of CNY 215.32 million, CNY 283.74 million, and CNY 233.63 million, which accounted for 9.12%, 17.57%, and 19.51% of the reported revenues for those years respectively [2][7]. - The inflated profit totals were CNY 56.40 million, CNY 63.38 million, and CNY 43.70 million, representing 35.62%, 88.23%, and 6.42% of the reported profits for the respective years [2][7]. Group 2: Regulatory Actions and Consequences - The CSRC has ordered *ST Changyao to correct its financial statements and has issued warnings along with fines to the company and responsible personnel [2][3]. - The company may face mandatory delisting due to continuous false reporting of financial indicators over three years, as per the Shenzhen Stock Exchange's regulations [3][9]. - Prior to the administrative penalty, *ST Changyao had received a notice of investigation from the CSRC regarding the alleged false reporting of financial data [3][9]. Group 3: Investor Compensation and Legal Actions - A law firm is collecting claims from investors who purchased *ST Changyao's securities between April 28, 2022, and November 6, 2025, and who sold or held their investments after November 7, 2025 [4][9]. - Investors are advised to register for compensation claims, which may include losses from investment differences, commissions, and stamp duties [3][4]. - Required documentation for claims includes identification, securities account information, and transaction records [10].

今日看点 ▼聚焦一：思林杰：终止发行股份及支付现金购买资产并募集配套资金事项 公司原拟通过发行股份及支付现金的方式购买科凯电子的股权同时配套募集资金，本次交易预计构成重大资产重组且构成 关联交易，不构成重组上市。由于本次交易规模较大、涉及相关方较多，使得重大资产重组方案论证历时较长。现公司综 合考虑市场环境较本次交易筹划初期已发生一定变化，经公司与交易各相关方友好协商、认真研究和充分论证，基于审慎 性考虑，决定终止本次交易事项并向上海证券交易所申请撤回本次交易事项的相关申请文件。 | 条 开 | 公司 | 主要内容 | | --- | --- | --- | | | 五矿新能 | 2025年度预盈2.1亿至2.5亿元 同比扭亏 | | | 招金黄金 | 2025年度预盈1.22亿至1.82亿元 同比扭亏 | | | 优博讯 | 2025年度预盈7200万元至1.07亿元 同比扭亏 | | | 厦门信达 | 2025年度预盈1500万元 同比扭亏 | | | 新强联 | 2025年净利润同比预增1093.07%-1307.21% | | | 永创智能 | 2025年净利润同比预增721.57%-894.86% ...

Market Overview - During the week from January 19 to January 23, A-shares showed mixed performance with the Shanghai Composite Index closing at 4136.16 points, up 0.83%, the Shenzhen Component Index at 14439.66 points, up 1.11%, and the ChiNext Index at 3349.50 points, down 0.34% [1] - Over 77% of stocks experienced gains during the week, with 237 stocks rising over 15%, while only 14 stocks fell more than 15% [1] - Sectors such as building materials, oil and petrochemicals, steel, and basic chemicals saw increases, while banking, telecommunications, non-bank financials, and food and beverage sectors declined [1] Top Gainers - *ST Lifan (300344.SZ) topped the weekly gainers with a remarkable 95.52% increase, followed by *ST Changyao (300391.SZ) with a 70.37% rise, and Fenglong Co. (002931.SZ) at 61.08% [2] - Other notable gainers included Zhizhi New Materials (300986.SZ) at 49.21%, Jiamei Packaging (002969.SZ) at 48.15%, and Hunan Silver (002716.SZ) at 47.44% [2] Company Profile of *ST Lifan - *ST Lifan is a digital technology cloud service provider focused on new digital infrastructure, with main business segments including intelligent hardware and software, digital intelligent services, and mobile information services [3] - The company's actual controller made unauthorized public statements that led to stock price fluctuations, prompting a clarification announcement from the company [3] Regulatory Concerns - On January 23, the Anhui Securities Regulatory Bureau reported that *ST Lifan faces a significant risk of forced delisting due to suspected false financial reporting for three consecutive years (2021, 2022, 2023) [4] - The company has been issued a notice regarding administrative penalties and market entry bans, and is currently in the process of appealing [4] - The regulatory body emphasized the importance of relying on official announcements from the company to avoid misinformation [4]

当地时间1月23日，美国南方司令部表示，当日在"战争部长"（国防部长）赫格塞思 的指示下，"南方之矛"联合特遣部队对一艘船只实施了致命打击，该船只被认定为 由"恐怖组织"运营。 南方司令部表示，情报证实，"该船只正在东太平洋沿已知毒品走私路线航行，并参与毒品走 私活动"， 两名"毒贩"在袭击中死亡，一人生还 。袭击结束后，美国南方司令部通知美国海 岸警卫队启动搜救系统，搜寻幸存者。 综合自：央视新闻 责编：叶舒筠 校对： 刘星莹 END 点击关键字可查看 潜望系列深度报道丨 股事会专栏 丨 投资小红书 丨 e公司调查 丨 时报会客厅 丨 十大明星私募访谈 丨 又一商业火箭企业，完成IPO辅导！ 丨 芯片巨头，暴跌超17%！ 丨 财务造假！300391，收终止 上市事先告知书！股价刚4连涨停 丨 002931，18连板！深交所出手，暂停部分投资者账户交易 丨 今夜，业绩利好！300850，去年净利暴增超10倍！ 丨 罚没超10亿元！牛散控制67个账户操纵股 票，证监会开出罚单！ 丨 罚单创"史上最重"！证监会严查私募机构瑞丰达 丨 大爆发！601012，午 后涨停 丨 电力设备板块，涨停潮！ 丨 鼎益丰案最新！ ...

Core Viewpoint - *ST Changyao has been penalized for financial fraud, facing a fine of 10 million yuan and a proposed termination of its stock listing due to serious violations over three consecutive years [2][5][7]. Group 1: Financial Penalties and Violations - The company was fined 10 million yuan for financial fraud, as confirmed by the China Securities Regulatory Commission (CSRC) [2][5]. - The CSRC has indicated that it will transfer any criminal evidence related to the case to the public security authorities for further investigation [2]. - The company has been found to have inflated revenue and profit figures in its annual reports from 2021 to 2023, with inflated revenues of 215 million yuan, 284 million yuan, and 234 million yuan, representing 9.12%, 17.57%, and 19.51% of reported revenues respectively [5]. Group 2: Stock Listing Status - The Shenzhen Stock Exchange has issued a notice proposing to terminate the company's stock listing, with trading suspension set to begin on January 26, 2026 [6][7]. - The company has already triggered conditions for mandatory delisting due to significant legal violations [9]. - The stock has experienced a significant price increase, with a cumulative rise of 107.75% over four trading days leading up to January 23, 2026 [9].

Core Viewpoint - *ST Changyao has been penalized for financial fraud, facing a fine of 10 million yuan and a proposed termination of its stock listing due to serious violations over three consecutive years [1][2]. Group 1: Financial Fraud Details - The company was found to have inflated revenue by 215 million yuan, 284 million yuan, and 234 million yuan for the years 2021, 2022, and 2023 respectively, which accounted for 9.12%, 17.57%, and 19.51% of the reported revenue for those years [4]. - The inflated total profit for the same years was 56.4 million yuan, 63.4 million yuan, and 43.7 million yuan, representing 35.62%, 88.23%, and 6.42% of the reported profit [4]. - An additional profit inflation of 4.55 million yuan was noted for 2022 due to improper loss recognition related to a project, which constituted 6.34% of the reported profit for that year [5]. Group 2: Regulatory Actions - The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision on January 23, confirming the company's violations and imposing a fine [2][5]. - The company is subject to potential criminal prosecution as the CSRC has indicated it will refer any criminal evidence to the public security authorities [1]. - According to the Shenzhen Stock Exchange rules, the company has triggered conditions for mandatory delisting due to significant legal violations [8]. Group 3: Market Reaction - *ST Changyao's stock experienced a significant increase, with a cumulative price increase of 41.44% over two trading days and 107.75% over four trading days leading up to January 23 [8]. - As of January 23, the stock closed at 0.92 yuan per share, with a total market capitalization of 322 million yuan [8].

Group 1 - *ST Changyao has been found to have committed violations related to financial reporting, including the acquisition of 52.75% of Hubei Changjiang Star Pharmaceutical Co., Ltd. in November 2020, which was subsequently consolidated into its financial statements [2] - From 2021 to 2023, subsidiaries of Changjiang Star fabricated inventory and sales documents, leading to inflated revenues of 215.32 million, 283.74 million, and 233.63 million yuan for the respective years, representing 9.12%, 17.57%, and 19.51% of reported revenues [3] - The inflated total profits for the same years were 56.40 million, 63.38 million, and 43.71 million yuan, accounting for 35.62%, 88.23%, and 6.42% of the reported total profits [3] Group 2 - The company has been warned that its financial reporting from 2021 to 2023 contains false records, which may lead to the termination of its stock listing under the revised rules of the Growth Enterprise Market [3] - As of January 23, *ST Changyao's stock has experienced a continuous rise, with a total increase of 109.09%, reaching a price of 0.92 yuan per share and a market capitalization of 322 million yuan [4] Group 3 - The current regulatory environment is increasingly focused on combating financial fraud, with multiple departments collaborating to strengthen oversight and enforcement against such practices [6] - A recent meeting highlighted a shift in regulatory strategy from reactive punishment to proactive prevention and comprehensive accountability across all parties involved, including major shareholders and intermediaries [6] - The establishment of a comprehensive prevention and punishment system aims to enhance the integrity of the capital market, ensuring that fraudulent activities are met with severe consequences and that investors have avenues for compensation [6]